Novartis to acquire Tourmaline Bio for $1.4 billion - Reuters

Reuters | Sept. 9, 2025, 7:23 a.m. | Original
Novartis to acquire Tourmaline Bio for $1.4 billion Reuters
Eli Lilly launches platform for AI-enabled drug discovery - Reuters ASML-Mistral AI deal boosts Europe tech hopes as Trump rivalry heats up - Reuters